Computational modelling approaches to vaccinology

Pharmacological Research

Volumn 92, Issue , 2015, Pages 40-45

  Pappalardo, Francesco ^a   Flower, Darren ^b   Russo, Giulia ^a   Pennisi, Marzio ^a   Motta, Santo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Computational vaccinology; Epitopes; Immune system; Modelling; Simulations; Vaccine research

Indexed keywords

CANCER VACCINE; EPITOPE; IMMUNOLOGICAL ADJUVANT; PATTERN RECOGNITION RECEPTOR; SMALL MOLECULE ADJUVANT; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; PATHOGEN ASSOCIATED MOLECULAR PATTERN; VACCINE;

ADVERSE DRUG REACTION; CANCER IMMUNOTHERAPY; COMPUTER MODEL; COMPUTER PREDICTION; COMPUTER SIMULATION; CYTOTOXIC T LYMPHOCYTE; DRUG SCREENING; EPITOPE MAPPING; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MAJOR HISTOCOMPATIBILITY COMPLEX; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; ORGAN TRANSPLANTATION; PATHOGEN ACTIVATED MOLECULAR PATTERN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRTUAL REALITY; ANIMAL; BIOLOGICAL MODEL; IMMUNIZATION; IMMUNOLOGY;

ANIMALS; EPITOPES; HUMANS; IMMUNIZATION; MODELS, BIOLOGICAL; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; VACCINES;

EID: 84923314264     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2014.08.006     Document Type: Review

References (59)

1. F. Pappalardo, P.L. Lollini, F. Castiglione, and S. Motta Modeling and simulation of cancer immunoprevention vaccine Bioinformatics 21 12 2005 2891 2897
2. P. Nanni, G. Nicoletti, C. De Giovanni, L. Landuzzi, E. Di Carlo, and F. Cavallo Combined allogeneic tumor cell vaccination and systematic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice J Exp Med 194 9 2001 1195 1205
3. A. Palladini, G. Nicoletti, F. Pappalardo, A. Murgo, V. Grosso, and V. Stivani In silico modeling and in vivo efficacy of cancer-preventive vaccinations Cancer Res 70 20 2010 7755 7763
4. F. Pappalardo, M. Pennisi, F. Castiglione, and S. Motta Vaccine protocols optimization: in silico experiences Biotechnol Adv 28 1 2010 82 93
5. P. Nanni, G. Nicoletti, A. Palladini, S. Croci, A. Murgo, and A. Antognoli Antimetastatic activity of a preventive cancer vaccine Cancer Res 67 22 2007 11037 11044
6. M. Pennisi, F. Pappalardo, A. Palladini, G. Nicoletti, P. Nanni, and P.-L. Lollini Modeling the competition between lung metastases and the immune system using agents BMC Bioinform 11 2010 S7 S13
7. F. Pappalardo, E. Mastriani, P.L. Lollini, and S. Motta Genetic algorithm against cancer Lect Notes Comput Sci 3849 2006 223 228
8. M. Pennisi, R. Catanuto, F. Pappalardo, and S. Motta Optimal vaccination schedules using simulated annealing Bioinformatics 24 15 2008 1740 1742
9. J.V. Ponomarenko, and P.E. Bourne Antibody-protein interactions: benchmark datasets and prediction tools evaluation Bmc Struct Biol 7 2007 64
10. M.J. Blythe, D.R. Flower, and B. Benchmarking cell epitope prediction: underperformance of existing methods Protein Sci 14 2005 246 248
11. E.M. Lafuente, and P.A. Reche Prediction of MHC-peptide binding: a systematic and comprehensive overview Curr Pharm Des 15 2009 3209 3220
12. U. Gowthaman, and J.N. Agrewala In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion J Proteome Res 7 2008 154 163
13. Y. El-Manzalawy, D. Dobbs, and V. Honavar On evaluating MHC-II binding peptide prediction methods PLoS ONE 3 2008 e3268
14. H.H. Lin, G.L. Zhang, S. Tongchusak, E.L. Reinherz, and V. Brusic Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research Bmc Bioinform 9 Suppl. 12 2008 S22
15. H. Zhang, P. Wang, N. Papangelopoulos, Y. Xu, A. Sette, and P.E. Bourne Limitations of Ab initio predictions of peptide binding to MHC class II molecules PLoS ONE 5 2010 e9272
16. B. Knapp, U. Omasits, S. Frantal, and W. Schreiner A critical cross-validation of high throughput structural binding prediction methods for pMHC J Comput Aided Mol Des 23 2009 301 307
17. I.K. Macdonald, M. Harkiolaki, L. Hunt, T. Connelley, A.V. Carroll, and N.D. MacHugh MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors PLoS Pathog 6 10 2010 e1001149
18. K.W. Jørgensen, M. Rasmussen, S. Buus, and M. Nielsen NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery Immunology 141 1 2014 18 26
19. E. Karosiene, M. Rasmussen, T. Blicher, O. Lund, S. Buus, and M. Nielsen NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ Immunogenetics 65 10 2013 711 724
20. E. Karosiene, C. Lundegaard, O. Lund, and M. Nielsen NetMHCcons: a consensus methodfor the major histocompatibility complex class I predictions Immunogenetics 64 3 2012 177 186
21. M. Halling-Brown, R. Shaban, D. Frampton, C.E. Sansom, M. Davies, and D. Flower Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design Mol Immunol 46 13 2009 2699 2705
22. I.A. Doytchinova, and D.R. Flower Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties Vaccine 25 5 2007 856 866
23. I.A. Doytchinova, and D.R. Flower VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines BMC Bioinform 8 2007 4
24. S. Ivona, F. Bernante, and F. Filippini NERVE: new enhanced reverse vaccinology environment BMC Biotechnol 6 2006 35
25. M.E. Bianchi DAMPs, PAMPs and alarmins: all we need to know about danger J Leukoc Biol 81 1 2007 1 5
26. D.R. Flower Systematic identification of small molecule adjuvants Expert Opin Drug Discov 7 9 2012 807 817
27. C.H. Kim Migration and function of Th17 cells Inflamm Allergy Drug Targets 8 3 2009 221 228
28. J. Bayry, D.R. Flower, D.F. Tough, and S.V. Kaveri From 'perfect mix' to 'potion magique' - regulatory T cells and anti-inflammatory cytokines as adjuvant targets Nat Rev Microbiol 6 1 2008 C1 author reply C2
29. J. Bayry, E.Z. Tchilian, M.N. Davies, E.K. Forbes, S.J. Draper, and S.V. Kaveri In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination Proc Natl Acad Sci U S A 105 29 2008 10221 10226
30. C. McInnes Virtual screening strategies in drug discovery Curr Opin Chem Biol 11 5 2007 494 502
31. P. Ripphausen, B. Nisius, L. Peltason, and J. Bajorath Quo vadis, virtual screening? A comprehensive survey of prospective applications J Med Chem 53 24 2010 8461 8467
32. J. Bajorath Computational studies, virtual screening, and theoretical molecular models J Med Chem 53 1 2010 1 2
33. C.K. Hattotuwagama, M.N. Davies, and D.R. Flower Receptor-ligand binding sites and virtual screening Curr Med Chem 13 11 2006 1283 1304
34. M.N. Davies, J. Bayry, E.Z. Tchilian, J. Vani, M.S. Shaila, and E.K. Forbes Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors PLoS ONE 4 11 2009 e8084
35. H. Pere, Y. Montier, J. Bayry, F. Quintin-Colonna, N. Merillon, and E. Dransart A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens Blood 118 18 2011 4853 4862
36. A.W. Michels Targeting the trimolecular complex Clin Immunol 2013
37. A.W. Michels, D.A. Ostrov, L. Zhang, M. Nakayama, M. Fuse, and K. McDaniel Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation J Immunol 187 11 2011 5921 5930
38. A.W. Michels, D.A. Ostrov, L. Zhang, M. Nakayama, M.A. Atkinson, and G.S. Eisenbarth Identification of small molecules that enhance anti-insulin peptide T Cell receptor signaling and IL-10 secretion Diabetes 59 2010 A89-A89
39. M. Aihara Pharmacogenetics of cutaneous adverse drug reactions J Dermatol 38 3 2011 246 254
40. O. Hausmann, B. Schnyder, and W.J. Pichler Etiology and pathogenesis of adverse drug reactions Chem Immunol Allergy 97 2012 32 46
41. D.R. Flower, K. Phadwal, I.K. Macdonald, P.V. Coveney, M.N. Davies, and S. Wan T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges Immunome Res 6 Suppl. 2010 2:S4
42. S. Wan, D.R. Flower, and P.V. Coveney Toward an atomistic understanding of the immune synapse: large-scale molecular dynamics simulation of a membrane-embedded TCR-pMHC-CD4 complex Mol Immunol 45 5 2008 1221 1230
43. K.Y. Sanbonmatsu, and C.S. Tung High performance computing in biology: multimillion atom simulations of nanoscale systems J Struct Biol 157 3 2007 470 480
44. M. Price Computational biologists: the next pharma scientists? Sci Carrier Mag 2012 10.1126/science.caredit.a1200041
45. F. Pappalardo, I.M. Forero, and M. Pennisi SimB16: modeling induced immune system response against B16-melanoma PLoS ONE 6 10 2012 e26523 10.1371/journal.pone.0026523
46. P.S. Kim, and P.P. Lee Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach PLoS Comput Biol 8 10 2012 e1002742 10.1371/journal.pcbi.1002742
47. J. Von Eichborn, A.-L. Woelke, F. Castiglione, R. Preissner, and VaccImm: Simulating peptide vaccination in cancer therapy BMC Bioinform 14 2013 127
48. C. Bianca, and M. Pennisi The triplex vaccine effects in mammary carcinoma: a nonlinear model in tune with SimTriplex Nonlinear Anal: Real World Appl 13 4 2012 1913 1940
49. C. Bianca, F. Chiacchio, F. Pappalardo, and M. Pennisi Mathematical modeling of the immune system recognition to mammary carcinoma antigen BMC Bioinform 13 Supp. 17 2012 S21
50. M. Pennisi A mathematical model of immune system-melanoma competition Comput Math Methods Med 2012 13 10.1155/2012/850754
51. C.L. Davis, R. Wahid, F.R. Toapanta, J.K. Simon, M.B. Sztein, and D. Levy Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics PLoS ONE 8 4 2013 e59465 10.1371/journal.pone.0059465
52. F. Pappalardo, M. Pennisi, A. Ricupito, F. Topputo, and M. Bellone Induction of T cell memory by a dendritic cell vaccine: a computational model Bioinformatics 30 13 2014 1884 1891 10.1093/bioinformatics/btu059
53. Z.P. Parra-Guillen, P. Berraondo, E. Grenier, B. Ribba, and I.F. Troconiz Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategies The AAPS Journal 15 3 2013 797 807
54. B. Joshi, X. Wanga, S. Banerjeea, H. Tianb, A. Matzavinos, and M.A.J. Chaplain On immunotherapies and cancer vaccination protocols: a mathematical modelling approach J Theor Biol 259 2009 820 882
55. C. DeLisi, and J.A. Berzofsky T-cell antigenic site stend to be amphipathic structures Proc Natl Acad Sci U S A 82 20 1985 7048 7052
56. N. Kumar, B.S. Hendriks, K.A. Janes, D. de Graaf, and D.A. Lauffenburger Applying computational modeling to drug discovery and development Drug Discov Today 11 17/18 2006 806 811
57. R.D. Fleischmann, M.D. Adams, and O. White Whose genome random sequencing and assembly of Haemophilus influenzae Rd Science 269 5223 1995 496 521
58. R. Rappuoli Reverse vaccinology Curr Opin Microbiol 3 5 2000 445 450
59. A.S. De Groot, J. McMurry, L. Moise, and B. Martin Epitope-based immunome-derived vaccines: a strategy for improved design and safety A. Falus, Applications of immunomics 2009 Springer Immunomics Series, Springer New York, NY, USA